Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Enovis CORP
| Metric | Enovis CORP ENOVHealthcare |
|---|---|
| Quality Score | 57 / 100 |
| Revenue (latest) | $2.25B |
| Net income (latest) | −$1.18B |
| Operating margin | −50.0% |
| Net margin | −52.7% |
| Return on equity | −79.5% |
| Return on assets | −30.9% |
| Return on capital (ROCE) | −34.7% |
| Debt / equity | 1.57× |
| Revenue growth (YoY) | 6.7% |
| Altman Z″ (distress) | -1.51 |
| Accruals / assets | −36.6% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.